BFM
IBB icon

Boothbay Fund Management’s iShares Biotechnology ETF IBB Stock Holding History

Boothbay Fund Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,300
Closed -$334K – 612
2015
Q3 		$334K Buy
+3,300
New +$396K 0.16% 158

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Boothbay Fund Management's IBB Position: Q2 2022 in Review

Boothbay Fund Management sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 6,866 shares — an estimated $895K sold.

Boothbay Fund Management first reported a position in IBB in Q3 2015 and held it in 7 quarters. The position peaked at $3.71M in Q4 2021. 858 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

  • Boothbay Fund Management reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 6,866 iShares Biotechnology ETF shares in Q2 2022, an estimated $895K.
  • Boothbay Fund Management first reported a position in iShares Biotechnology ETF in Q3 2015 and held it in 7 quarters.
  • Boothbay Fund Management's iShares Biotechnology ETF position peaked at $3.71M in Q4 2021.
  • 858 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on Boothbay Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.